The Latest Breaking News from FDA

A third-party lab caught OpenAI's o1 model trying to deceive, while OpenAI's safety testing has been called into question.

The drug Librela was approved to control pain associated with osteoarthritis in dogs.

In the expanding oncology market, Exelixis (EXEL) is gaining attention with its strong pipeline and impressive stock performance. With a clear focus on cancer treatment innovation and a growing market presence, is the company set to lead the future of cancer care and treatment? Read more….

The illegal sale of unapproved Korean botulinum toxin products raises serious health concerns amid the K-beauty boom.

Five infants required hospitalization, with one needing mechanical ventilation.

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns

Senate Republican leader Mitch McConnell, a childhood polio survivor, said any of President-elect Donald Trump’s nominees seeking confirmation should “steer clear” of efforts to discredit the polio vaccine

Unpasteurised milk, seen as both anti-government and anti-corporate, soars in popularity among conspiracy theorists and new agers

For some, this supplement has replaced many medications including for substance use disorder